Predictive Oncology Inc.
13F holders, Q1 2025 (March 31)14holders −2
2new positions
4sold out
$1.52avg. 13F price*
At the end of Q1 2025, 14 institutions reported holding Predictive Oncology Inc. in their 13F filings, down 2 from Q4 2024. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($108K), Geode Capital Management, LLC ($96K) and UBS Group AG ($29K).
- Company
- Predictive Oncology Inc.
- CUSIP
- 74039M309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 4 | $72K |
All 13F filers, Q4 2024 → Q1 2025: 31,093 shares bought and 87,233 shares sold, net −56,140 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Group Inc. | 0.00% | No change | 71,307 | $108K |
| Geode Capital Management, LLC | 0.00% | Add +22.9% | 62,931 | $96K |
| UBS Group AG | 0.00% | New | 18,977 | $29K |
| State Street Corp. | 0.00% | No change | 13,837 | $21K |
| Carnegie Mellon University | 0.01% | No change | 10,358 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +6.9% | 5,199 | $8K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 425 | $645 |
| PSI Advisors, LLC | 0.00% | No change | 399 | $606 |
| Citigroup Inc. | 0.00% | New | 54 | $82 |
| Bank of America Corp. | 0.00% | Add +3.9% | 53 | $81 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 50 | $76 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -64.3% | 5 | $8 |
| Royal Bank of Canada | 0.00% | No change | 50 | $0 |
"% of holder's portfolio" is PREDICTIVE ONCOLOGY INC's weight in each manager's 13F, not the share of Predictive Oncology Inc. the manager owns.